Literature DB >> 8991643

Release of soluble tumor necrosis factor receptors in Mediterranean spotted fever rickettsiosis.

W V Kern1, J Oristrell, F Segura-Porta, P Kern.   

Abstract

Tumor necrosis factor alpha (TNF) is a key cytokine in the defense against many intracellular pathogens, including Rickettsia conorii, the causative agent of Mediterranean spotted fever (MSF). The levels of two soluble TNF receptors (sTNFR-p55 and sTNFR-p75), the extracellular domains of the two cell surface receptors for TNF, were elevated in the acute-stage plasma samples from 20 patients with serologically confirmed MSF. The median values were 3.1 and 7.8 ng/ml for sTNFR-p55 and sTNFR-p75, respectively. sTNFR values correlated significantly with plasma TNF concentrations. Patients with severe MSF had higher values for both receptor fragments than patients with nonsevere disease. The differences were statistically significant for sTNFR-p55 (median, 5.8 versus 2.0 ng/ml; P = 0.008). Given the proportionately higher values for both TNF and sTNFR-p55 in patients with severe MSF, the sTNFR-p55/TNF ratios for the two patient subgroups did not differ (P = 0.5), while the sTNFR-p75/TNF ratios were significantly different (P = 0.01), with disproportionately lower values in patients with severe disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8991643      PMCID: PMC170287          DOI: 10.1128/cdli.3.2.233-235.1996

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  21 in total

Review 1.  Two TNF receptors.

Authors:  L A Tartaglia; D V Goeddel
Journal:  Immunol Today       Date:  1992-05

2.  Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon.

Authors:  E Manor; I Sarov
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

Review 3.  Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor.

Authors:  L A Tartaglia; M Rothe; Y F Hu; D V Goeddel
Journal:  Cell       Date:  1993-04-23       Impact factor: 41.582

4.  Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity.

Authors:  H Engelmann; H Holtmann; C Brakebusch; Y S Avni; I Sarov; Y Nophar; E Hadas; O Leitner; D Wallach
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

5.  Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia.

Authors:  G A Spinas; U Keller; M Brockhaus
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

6.  Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria.

Authors:  P Kern; C J Hemmer; H Gallati; S Neifer; P Kremsner; M Dietrich; F Porzsolt
Journal:  J Infect Dis       Date:  1992-10       Impact factor: 5.226

7.  Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group.

Authors:  E Girardin; P Roux-Lombard; G E Grau; P Suter; H Gallati; J M Dayer
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

8.  Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.

Authors:  K J Van Zee; T Kohno; E Fischer; C S Rock; L L Moldawer; S F Lowry
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

9.  Plasma levels of tumor necrosis factor alpha in patients with Mediterranean spotted fever: clinical and analytical correlations.

Authors:  J Oristrell; M J Amengual; B Font-Creus; A Casanovas; F Segura-Porta
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079

10.  Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55.

Authors:  F Mackay; H Loetscher; D Stueber; G Gehr; W Lesslauer
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Host, pathogen and treatment-related prognostic factors in rickettsioses.

Authors:  E Botelho-Nevers; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-26       Impact factor: 3.267

2.  Plasma interleukin-6 levels in Mediterranean spotted fever.

Authors:  J Oristrell; M Sampere; M J Amengual; B Font; F Segura
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-22       Impact factor: 3.267

3.  Significantly higher cytokine and chemokine levels in patients with Japanese spotted fever than in those with Tsutsugamushi disease.

Authors:  Katsunori Tai; Hiromichi Iwasaki; Satoshi Ikegaya; Nobuhiro Takada; Yukiko Tamaki; Kenji Tabara; Takanori Ueda
Journal:  J Clin Microbiol       Date:  2014-03-26       Impact factor: 5.948

4.  Increased levels of macrophage colony-stimulating factor, gamma interferon, and tumor necrosis factor alpha in sera of patients with Orientia tsutsugamushi infection.

Authors:  H Iwasaki; N Takada; T Nakamura; T Ueda
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

Review 5.  New insight into immunity and immunopathology of Rickettsial diseases.

Authors:  Pasquale Mansueto; Giustina Vitale; Antonio Cascio; Aurelio Seidita; Ilenia Pepe; Antonio Carroccio; Salvatore di Rosa; Giovam Battista Rini; Enrico Cillari; David H Walker
Journal:  Clin Dev Immunol       Date:  2011-09-06

6.  Prediction of Disseminated Intravascular Coagulation by Liver Function Tests in Patients with Japanese Spotted Fever.

Authors:  Yuichi Miyashima; Masaya Iwamuro; Michihiko Shibata; Yoshio Miyabe; Yoshinari Kawai; Masanobu Kaihara; Takehide Mitogawa; Masaru Harada
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.